UnitedHealth DOJ Medicare Billing Investigation
UnitedHealth Faces Renewed DOJ Scrutiny Over Medicare Advantage Practices
Washington D.C. – UnitedHealth Group is once again under the microscope of the Department of Justice (DOJ) regarding its Medicare Advantage business practices. The DOJ has reportedly interviewed doctors to investigate allegations that UnitedHealth pressured them to submit claims for specific conditions, a move that could inflate payments from the Medicare Advantage program.
This progress marks the second federal probe into the insurer’s Medicare advantage operations this year. In February, The Wall Street Journal reported that the DOJ had initiated a civil investigation into whether the company had artificially inflated diagnoses to secure additional payments for its Medicare Advantage plans.
However, UnitedHealth has pushed back against the scrutiny. In a statement released Thursday, the company asserted that independent audits conducted by the Centers for Medicare and Medicaid Services (CMS) “confirm” that its practices are “among the most accurate in the industry.”
The company also highlighted a March suggestion from a special master, who sided with UnitedHealth in a protracted legal dispute with the DOJ. The case originated from a whistleblower’s claim that UnitedHealth had illegally withheld at least $2 billion through the medicare Advantage program. The special master, appointed by a judge, concluded that the DOJ lacked sufficient evidence to support its claims.
UnitedHealthcare’s Medicare and retirement segment, wich encompasses its Medicare Advantage business, is a significant revenue generator for UnitedHealth Group, bringing in $139 billion in sales last year.
the renewed focus on the DOJ probe comes after a challenging year for UnitedHealth. shares of its parent company, UnitedHealth Group, have fallen more than 42% year-to-date. This decline follows the company’s decision to suspend its 2025 forecast due to soaring medical costs, the unexpected departure of CEO Andrew Witty, and the ongoing investigations into its Medicare Advantage business.The company’s difficulties extended into 2024, which was also marred by a significant cyberattack and widespread public backlash following the murder of UnitedHealthcare CEO Brian Thompson.
Key Takeaways:
The DOJ is reportedly investigating UnitedHealth’s Medicare Advantage practices, including allegations of pressuring doctors to submit claims that boost payments.
This is the second federal probe into the company’s Medicare Advantage business this year.
UnitedHealth maintains that independent CMS audits confirm its practices are accurate and points to a special master’s ruling in its favor in a previous DOJ legal battle.
The Medicare Advantage segment is UnitedHealth group’s largest revenue driver.
The company has faced significant challenges recently, including a stock price decline, leadership changes, a cyberattack, and public scrutiny.